Annual Non Current Assets
$2.68 M
+$436.00 K+19.43%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual long term assets is $2.68 million, with the most recent change of +$436.00 thousand (+19.43%) on December 31, 2023.
- During the last 3 years, CTNM annual non current assets has risen by +$1.94 million (+262.65%).
- CTNM annual non current assets is now at all-time high.
Performance
CTNM Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$891.00 K
-$144.00 K-13.91%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly long term assets is $891.00 thousand, with the most recent change of -$144.00 thousand (-13.91%) on September 30, 2024.
- Over the past year, CTNM quarterly non current assets has dropped by -$1.79 million (-66.75%).
- CTNM quarterly non current assets is now -76.88% below its all-time high of $3.85 million, reached on March 31, 2024.
Performance
CTNM Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CTNM Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.4% | -66.8% |
| 3 y3 years | +262.6% | -60.3% |
| 5 y5 years | +262.6% | -60.3% |
CTNM Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.6% | -76.9% | at low |
| 5 y | 5-year | at high | +262.6% | -76.9% | at low |
| alltime | all time | at high | +262.6% | -76.9% | at low |
Contineum Therapeutics Class A Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $891.00 K(-13.9%) |
| Jun 2024 | - | $1.03 M(-73.1%) |
| Mar 2024 | - | $3.85 M(+43.8%) |
| Dec 2023 | $127.71 M | $2.68 M(+76.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.52 M(-32.4%) |
| Dec 2022 | $48.39 M(-30.6%) | - |
| Dec 2022 | - | $2.24 M |
| Dec 2021 | $69.78 M | - |
FAQ
- What is Contineum Therapeutics Class A annual long term assets?
- What is the all time high annual non current assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual non current assets year-on-year change?
- What is Contineum Therapeutics Class A quarterly long term assets?
- What is the all time high quarterly non current assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly non current assets year-on-year change?
What is Contineum Therapeutics Class A annual long term assets?
The current annual non current assets of CTNM is $2.68 M
What is the all time high annual non current assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual long term assets is $2.68 M
What is Contineum Therapeutics Class A annual non current assets year-on-year change?
Over the past year, CTNM annual long term assets has changed by +$436.00 K (+19.43%)
What is Contineum Therapeutics Class A quarterly long term assets?
The current quarterly non current assets of CTNM is $891.00 K
What is the all time high quarterly non current assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly long term assets is $3.85 M
What is Contineum Therapeutics Class A quarterly non current assets year-on-year change?
Over the past year, CTNM quarterly long term assets has changed by -$1.79 M (-66.75%)